Title: An Excess of Topical Calcium and Magnesium Reverses the Therapeutic Effect of Citrate on the Development of Corneal Ulcers After Alkali Injury
Author: Haddox-JL; Pfister-RR; Slaughter-SE, Eye Research Laboratories, Brookwood Medical Center, Birmingham, Alabama 35209, USA
Journal: Cornea. 1996 Mar; 15(2): 191-5
Abstract: Our purpose was to determine whether chelation of Ca2+ and Mg2+ is the mechanism by which sodium citrate inhibits corneal ulceration in the alkali-injured rabbit eye. The right eyes of 60 albino rabbits (2-2.5 kg) were alakali-injured by filling a 12-mm-diameter plastic well placed on the corneal surface with 0.4 ml of 1 N NaOH. After 35 s the alkali was aspirated, and the well was rinsed with physiological saline. Animals were randomly distributed to three treatment groups of equal size. Two drops of the following topical medications were administered on the hour (14 times a day) for 35 days: physiological saline, 10% citrate in saline, and 346 mM Ca2+, 346 mM Mg2+, and 10% citrate in saline. During the expriment, significantly fewer ulcerations occured in the citrate-treated eyes (5 of 20, 25%) than in the saline-treated eyes (15 of 20, 75%). When ulcerations did develop in the citrated group, they occured significantly later and were less severe than those in the saline and calcium-magnesium-citrate groups. There was a significant increase in the number of eyes with signs of band keratophy and translucent areas in the calcium-magnesium-citrate group when compared with the other two groups. As in previous studies, soduim citrate significantly inhibited the development of corneal ulcers after alkali injury. The annullment of the favorable effect of citrates on ulceration in the alkali-injured eye by the addition of calcium and magnesium shows that the mechanism of action of citrate is the chelation of these divalent cation.
![]()
Copyright © 2007 The Morgan
Lens by MorTan Inc. All Rights Reserved.
To provide you with the highest quality products,
MorTan has obtained the following quality certifications: ISO 9001, EN
46001, ISO 13485, CMDCAS. In addition, all of MorTan's products carry the CE
mark and are manufactured using the US Food and Drug Administration's current
Good Manufacturing Practices.

![]()
MorTan, Inc.
P.O. Drawer 8719
Missoula, MT 59807-8719
Toll Free: (800) 423-8659
Local: (406) 728-2522
Fax: (406) 728-9332
![]()